bpc 157 and parkinson's Heal or Harm: Body Protective Compound-157 in the Gray Zone Sample of patents with BPC

Key Research Findings CAM Assay: BPC-157 increases blood vessel formation in chorioallantoic membrane models Wound Models: Enhanced angiogenesis observed in cutaneous wound healing studies VEGF Blockade: VEGF inhibitors (bevacizumab) partially block BPC-157's healing effects, confirming VEGF involvement L-NAME Studies: NOS inhibition reduces BPC-157 efficacy, confirming NO pathway involvement Potential Applications The angiogenic mechanism suggests utility in: Chronic Wounds: Diabetic ulcers and pressure sores with impaired healing Sports Injuries: Tendon, ligament, and muscle repair Post-Surgical: Accelerating anastomotic and incisional healing Ischemic Conditions: Enhancing blood supply to poorly perfused tissues Considerations Cancer Context: Angiogenesis is a concern in malignancy

Research suggests GHK-Cu also has antioxidant properties, protects against oxidative stress, and may support DNA repair, contributing to overall skin and tissue health

PMCID: PMC10748240

Some users report headaches associated with nasal peptide administration

It is NOT recommended to place in the freezer